Direct-to-Implant Breast Reconstruction: Patient Selection, Technique and Evidence

Direct-to-implant (DTI) reconstruction places the definitive implant at the time of mastectomy, completing the reconstruction in a single operation and sparing the patient the expansion visits and second surgery of the two-stage pathway. Done in the right patient it is one of the most satisfying operations in breast surgery; done in the wrong one it courts skin necrosis and implant loss. This overview for healthcare professionals summarises what the literature says about selecting patients for DTI, and where soft-tissue support fits.

Why selection decides everything

DTI concentrates all the reconstructive risk into one moment: the mastectomy flaps must be able to nourish themselves over a full-volume implant from day one. Colwell and colleagues, whose Boston series helped define the modern technique (Gland Surgery 2015), describe the operation as an exercise in flap assessment; the implant is only as safe as the skin above it. Two-stage expander reconstruction remains the forgiving default when flap quality is in doubt.

Patient factors that favour DTI

• Well-perfused mastectomy flaps. The non-negotiable. Many units assess perfusion clinically plus, where available, with indocyanine green angiography before committing to an implant.
• Small to moderate breast size with minimal ptosis. The implant must fill the envelope without tension; large or ptotic breasts often need skin reduction or staging.
• Nipple-sparing or skin-sparing mastectomy performed through incisions that respect flap blood supply.
• Favourable biology and treatment plan. No inflammatory disease involving the skin; anticipated radiotherapy prompts a more cautious, individualised discussion.
• General factors. Non-smoking status, BMI in a workable range and well-controlled comorbidities all lower risk; in the De Vita 2024 multicentre prepectoral DTI series, higher complication risk was associated with high BMI and larger implant volume.

Relative cautions

Thin or damaged flaps, heavy smoking, prior chest-wall irradiation, very large implant requirements and significant ptosis are the recurring cautions across published series. None is an absolute bar in every unit, but each shifts the risk-benefit conversation toward staging with an expander, delayed reconstruction or an autologous option. Our patient-facing guide to reconstruction options maps the alternatives in plain language.

Where the matrix fits

Most modern DTI is performed in the prepectoral plane, and the implant therefore depends on a soft-tissue support layer rather than muscle. A biological matrix or ADM stabilises the pocket, defines the inframammary fold and supports the implant’s weight while integration proceeds. Published DTI series span the material families: ADM-based cohorts dominate the historical literature, and bovine pericardium DTI data now include the De Vita 2024 multicentre prepectoral series (65 breasts, 9.2% major complications, no significant capsular contracture at mean 21.3 months). How the material families compare is covered in our matrix versus ADM guide, and the published brand-level data in our bovine pericardium matrices comparison.

Technique notes from the literature

• Assess flaps after mastectomy, decide then. Consensus guidance keeps DTI, staged expander and delayed pathways all on the table until flap quality is known.
• Respect the envelope. Implant volume should restore, not stress, the skin; sizing to the mastectomy specimen and footprint beats maximising volume.
• Plan the refinement stage. Contour touch-ups with fat grafting are common and expected; building them into the patient conversation from the start avoids disappointment later.

The bottom line

DTI offers a single-operation reconstruction for the well-selected patient: good flaps, a proportionate envelope, favourable biology and a properly supported pocket. The published series agree on the fundamentals while differing in detail, and the safest units are those that treat DTI as a decision made in theatre, not in clinic. For the wider prepectoral pathway, see our prepectoral reconstruction pillar guide.

Key published sources

• Colwell AS. Direct-to-implant breast reconstruction. Gland Surgery. 2015.
• Margulies IG, Salzberg CA. Direct to implant breast reconstruction: visualized technique. Gland Surgery. 2019.
• Highton L, et al. Prepectoral implant-based breast reconstruction: a joint consensus guide. ecancermedicalscience. 2019.
• De Vita R, et al. Prepectoral direct-to-implant reconstruction with acellular bovine pericardium matrix, multicentre series. Clinical Breast Cancer. 2024.